Active Ingredient(s): Cysteine Hydrochloride
FDA Approved: * December 13, 2019
Pharm Company: * AVADEL LEGACY
Category: Neonatal (Infant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nouress Overview

Cysteine (symbol Cys or C;[3] /sstin/)[4] is a semiessential[5] proteinogenic amino acid with the formula HOOC-CH-(NH2)-CH2-SH. The thiol side chain in cysteine often participates in enzymatic reactions as a nucleophile. The thiol is susceptible to oxidation to give the disulfide derivative cystine, which serves an important structural role in many proteins. When used as a food additive, it has the E number E920. It is encoded by the codons UGU ...

Read more Nouress Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nouress Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cysteine Hydrochloride
  • Injection: 50mg/ml, 7.25%
  • Solution: 500mg/10ml (50mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nouress: (1 result)

Sorted by National Drug Code
  • 76014-006 Nouress 34.5 mg/ml Intravenous Injection by Avadel Legacy Pharmaceuticals, LLC

Other drugs which contain Cysteine Hydrochloride or a similar ingredient: (2 results)